Best stocks to buy this Independence Day 2023

As Independence Day approaches, investors find themselves at a juncture where patriotism meets financial prudence. This annual celebration not only commemorates the nation’s freedom but also presents a unique opportunity for individuals to exercise their financial independence through smart investment choices. The stock market, known for its dynamic and ever-evolving nature, offers a canvas upon which astute investors can paint their success stories.

In this article, we embark on a journey to uncover some of the most promising stocks poised for growth this Independence Day. Guided by thorough research and expert insights, we present a carefully curated list of potential investment opportunities that align with the spirit of progress and resilience that Independence Day represents.

GAIL INDIA LTD.

GAIL (India) Ltd., a prominent public sector undertaking, is a beacon of excellence in the energy sector. With its unwavering commitment to sustainable growth and innovation, GAIL has emerged as a key player in the natural gas and petrochemical industries. Its comprehensive network of pipelines spans the nation, facilitating the efficient and eco-friendly transportation of natural gas.

GAIL’s dedication to research and development continues to yield breakthroughs, contributing to India’s energy security and reducing its carbon footprint. Through its diverse portfolio and emphasis on responsible practices, GAIL remains a vital catalyst for India’s energy landscape, powering progress while prioritizing environmental stewardship.

Complex Cup and Handle pattern is formed where there is a cup and two handles. The stock price has already shown break out but has corrected again and available at support levels of Rs. 110-115. Short Term traders can buy it at this levels and make a potential gain of 24% till target of Rs. 140.

Divi’s Laboratories Ltd

Divi’s Laboratories Ltd., a distinguished name in the pharmaceutical landscape, exemplifies innovation and quality in drug manufacturing. With a focus on research-driven solutions, Divi’s has carved a niche in the Active Pharmaceutical Ingredients (APIs) and intermediates segment, catering to global pharmaceutical giants. Its state-of-the-art facilities and adherence to stringent regulatory standards underscore its commitment to producing safe and efficacious medicines.

Divi’s Labs’ consistent growth trajectory, bolstered by its unwavering dedication to excellence, positions it as a pivotal player in advancing healthcare on a global scale.

An excellent company which has turned into a multibagger for its investors is available at 34% downside from its lifetime high. Traders can invest in this company at levels of 3670 for a Target of Rs. 5384 for Potential gain of 46%.

Share Price has fallen that much because of poor results. This is the scenario in all pharma companies as they have reverted back to pre COVID sales growth.

Grindwell Norton Ltd.

Grindwell Norton Ltd., a distinguished name in the abrasives and ceramics industry, is synonymous with precision and quality. With decades of expertise, the company has crafted a niche in providing innovative abrasive solutions for a diverse range of industries, including automotive, aerospace, and construction. Grindwell Norton’s cutting-edge products and advanced manufacturing techniques reflect its unwavering commitment to enhancing efficiency and productivity for its global clientele. Its legacy of excellence, coupled with a focus on sustainability and customer-centricity, positions Grindwell Norton as a trusted partner in shaping surfaces and industries with precision and care.

With highest ever QoQ and YoY results, a cup and handle formation can be seen on the chart with potential gain of 28%.

Use the link to open a Demat account in Zerodha.

Disclaimer- All investments and trading in the stock market involve risk. Any decision to place a trade in the financial markets, including trading in stock should only be made after thorough research. Trading strategies or related information mentioned in the article is for informational purposes only. Use your due diligence before investing. These are just predictions. They may or may not be true. We are not SEBI-registered analysts.